Probiotics Antibiotic Associated Diarrhea Meta-analysis: What the Evidence Says

Quick Answer

Probiotics Antibiotic Associated Diarrhea Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 randomized trial.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• The authors did a good job of summarizing a large body of evidence, and their conclusion that probiotics help with childhood diarrhea agrees with the general scientific opinion. [Peng Yue (2026); evidence level 1]
• As a result, the total sample size is inflated, which narrows the confidence intervals for the summary effect estimate. [Peng Yue (2026); evidence level 1]
• Critical illness is often accompanied by a reduction in commensal microbiota and an overgrowth of potential pathogens, which increases the risk of sepsis, multiple organ dysfunction syndrome (MODS), ventilator-associated pneumonia (VAP), and hospital-acquired infections. [Jiang Yan (2026); evidence level 2]
• The beneficial effects of probiotics may be attributed to reduced bacterial translocation, stimulation of the commensal gut microbiota growth, and multiple mechanisms that prevent pathogenic overgrowth, including the production of metabolites (e.g., bacteriocins, hydrogen peroxide, lactic acid), nutrient competition, inhibition of pathogen adhesion, and toxin neutralization. [Jiang Yan (2026); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. There is trial evidence in the current set, but population and intervention details still matter. For probiotics antibiotic associated diarrhea meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Peng Yue (2026). Commentary: The effect of probiotics on the diarrhea and constipation outcomes in children: an umbrella review of systematic reviews and meta-analyses. DOI: 10.3389/fnut.2026.1762445. PMCID: PMC12968263. PMID: 41809106. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12968263/
• Jiang Yan (2026). Role of probiotic supplementation in preventing ventilator-associated pneumonia among critically ill patients—a critical umbrella review of meta-analyses of randomized controlled trials. DOI: 10.3389/fnut.2025.1719310. PMCID: PMC12983066. PMID: 41834846. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12983066/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.